METHOD OF TREATING PATIENTS WITH HYPERBILIRUBINEMIA Russian patent published in 2010 - IPC A61K36/50 A61K36/28 A61K33/00 A61K33/14 A61K31/472 A61P1/16 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, particularly to gastroenterology, and concerns treatments of the patients with hyperbilirubinemia. That is ensured by conventional pharmacotherapy combined with oral introduction of hepabene in a dose 1 capsule 3 times a day at mealtimes from the first day of treatment. From the next day, intravenous introductions of ozonised physiologic saline of table salt in volume 200 ml with ozone concentration 500 mcg/ml and introduction rate 8-10 ml/min is applied. The course includes 6 infusions every second day. After that preparation Hepabene is continued in a dose 1 capsule twice a day at mealtimes during 7-10 days.

EFFECT: method provides effective decrease in bilirubin with reduced treatment time.

2 ex